Giant Biogene Shareholders Approve Dividends and Resolutions

Giant Biogene Holding Co. Ltd. (HK:2367) has released an update.

Giant Biogene Holding Co., Ltd. announced the successful adoption of all proposed resolutions at their Annual General Meeting (AGM) on June 13, 2024, including the re-election of executive directors and the re-appointment of Ernst & Young as auditor. Shareholders approved a final dividend of RMB0.44 and a special dividend of RMB0.45 per share for 2023. Additionally, the company received a mandate to repurchase and issue shares, and adopted amended corporate documents.

For further insights into HK:2367 stock, check out TipRanks’ Stock Analysis page.